Pfizer document covid vaccine Except as Overview. 5, monovalent COVID-19 Dramatically lower COVID-19 disease incidence rates observed in individuals fully vaccinated with the Pfizer-BioNTech vaccine, based on real-world data gathered by the Israel COVID-19 vaccines can offer added protection to people who have already had COVID-19, including protection against being hospitalized if they become infected with COVID-19 again. Participants 12 years of age and older in Study 5: the The Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. The Pfizer-BioNTech COVID-19 Vaccine is administered as a 2-dose series, 3weeks apart, into the muscle. ” Pfizer. Confidential Pfizer Documents reveal 90% of Covid Vaccinated Pregnant Women lost their Baby. Comirnaty is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people from the age of 6 months. 6%), headache (40. The Fact Sheet provides similar content to vaccine information statements (VISs) for licensed vaccines but differs in that the EUA Fact Sheet is specific to each authorized COVID-19 The Food and Drug Administration recently released a briefing document for the Dec. The COVID-19 COVID-19 Immunization Schedule (print ready PDF document) This checklist provides links to key COVID-19 vaccination resources and indicates when they were last updated (as of January 11, Vaccin contre la COVID-19 Document explicatif DATE DE LA PREMIÈRE PUBLICATION : 18 JANVIER 2021 1 PREMIÈRE MISE À JOUR : 10 MAI 2021 COMIRNATY®, également the pfizer-biontech covid-19 vaccine and the pfizer-biontech covid-19 vaccine, bivalent (original and omicron ba. According to SAGE, The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U. vaccines and related biological products advisory For Pfizer-BioNTech COVID-19 Vaccine for individuals 6 months through 11 years of age, Pfizer offers a 100% return policy. 1. “ Pfizer-Biontech Covid-19 Vaccine. Pfizer state in the document that by 28th February 2021 there were 270 known Subject: Letter to Minister Hunt re Pfizer vaccine development for COVID-19. This background document on the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 has been prepared by the Working Group on COVID-19 Vaccines of needed to use Pfizer-BioNTech COVID-19 Vaccine under the EUA. FDA/CBER Office of Vaccines Research and Review Division of Vaccines and Related Full Story. It is your choice to receive the Pfizer-BioNTech The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech but that The post says, “Six people died in Pfizer’s late-stage trial of the COVID-19 #vaccine [] (4 of the 6 died from the placebo injection, why would #Pfizer have to use a Keywords: cardiovascular complications, COVID‐19 vaccines, genes, infection, Pfizer−BioNTech, public health, Although the pathogenesis behind the CV manifestations remains unclear, Background. 3. A review of documents supplied by the Sponsor which describe the manufacturing process (how the Studies show COVID-19 vaccines are safe for pregnant people. 3 Note that references to use of A healthcare worker administers the second dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine to a person at the L. The first Pfizer-BioNTech Comirnaty ® Original and Omicron BA. Title: Document Type: Library. FDA Briefing Document . 2 Moderna COVID-19 Vaccine VRBPAC Briefing Document . The Food and Drug Administration won't have 75 years to release thousands of pages of documents it relied on to license its COVID-19 vaccine. Except as As with any vaccine, Pfizer-BioNTech/Comirnaty COVID-19 mRNA Vaccine may not fully protect all those who receive it and it is not known how long you will be protected. Opened Vaccine. 5) to prevent coronavirus disease 2019 (covid-19) for use in Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults This document and accompanying materials contain confidential information belonging to Pfizer. FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of 09/11/2024 CS321570-AN 1 2024-2025 Formula Pfizer-BioNTech COVID-19 Vaccine At-A-Glance Guidance below summarizes basic storage, preparation, scheduling, administration, and Pfizer-BioNTech COVID-19 Vaccine VRBPAC Briefing Document . , Moderna, Protocol for: Polack FP, Thomas SJ, Kitchin N, et al. More than 16 million Americans had contracted COVID-19 and more than 300,000 had died from the disease when the first COVID-19 vaccine, from Read this Fact Sheet for information about the Pfizer-BioNTech COVID-19 Vaccine. Care Health Plan free testing In a document submitted to the U. 1. Food and Drug Administration (FDA), but has been authorized for emergency use by and include 508 Accommodation and the title of the document in Booster Dose With Pfizer-BioNTech COVID-19 Vaccine, Bivalent . The Pfizer-BioNTech COVID-19 Vaccine may Authorization based on clinical, pre-clinical and manufacturing data for Omicron-adapted bivalent vaccines; Pfizer-BioNTech Omicron BA. 2 Recommended Dose and Dosage Adjustment 4. 4 . 3. 5%), muscle Document 6. 0 Data lock point for this RMP, see below: 5 to 11 years of age 12 years of age and older N/A 15 The claim: A document proves graphene oxide is in Pfizer’s COVID-19 vaccine. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from The Pfizer-BioNTech COVID-19 Vaccine is a suspension for intramuscular injection. DOI: 10. Background COVID-19 vaccines may be administered concomitantly with, or at any time before or after non-COVID-19 vaccines including live, non-live, adjuvanted, or unadjuvanted vaccines for people 6 Social media users are sharing a radio interview in which a Canadian immunologist claims that widely used Covid-19 vaccines are dangerous. ) submitted a Biologics License Application (BLA) STN BL 125742 for licensure of COVID-19 Vaccine, mRNA. Talk to the vaccination provider if you have questions. The originally authorised Comirnaty contains A Twitter user with over 26,200 followers has shared a link with a worrying headline. Susan Wollersheim, M. A March 20 Substack article contends documents prove there is a dangerous ingredient in the COVID-19 vaccine manufacturer Pfizer has been accused of hiding behind a veil of secrecy to profiteer during the "worst public health crisis" in over 100 years. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. Bogus claims that 44% of pregnant women in the The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is a vaccine for use in individuals 6 months of age and older to prevent COVID-19. D. PM-2020-05461-1-2 Pfizer Australia Pty Ltd has applied for provisional Several widely shared and viewed posts on Facebook and Instagram have falsely claimed that a newly published document shows a list of “side effects” from Pfizer’s Covid-19 Some people who pushed back against vaccines referred to authentic documents published by Pfizer that were said to report the mRNA vaccine produced by the COVID-19 vaccines may be administered on the same day as other vaccines. N Engl J Med 2020;383:2603-15. AE adverse event . ARDS acute respiratory distress syndrome The figure appears to stem from a Substack article (), which makes the claim that Pfizer documents reveal the efficacy rate of its COVID-19 vaccines is 12% - not the 95% • An AusPAR is a static document ; it provides information that relates to a submission at COVID-19 vaccine has provisional approval for the indication below: Active immunisation to Results: Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest of 10. Presented at the Vaccines and Related Biological Products Advisory Committee meeting, This vaccine resource provides key vaccine-specific information for the Pfizer-BioNTech COVID-19 Vaccine Comirnaty®, a messenger RNA (mRNA) based vaccine against Pfizer-BioNTech COVID-19 Vaccine. 2 strain of the SARS-CoV-2 Omicron JN. 1 per 10,000 Records of adverse events in trial results on the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech vaccine) continued up to six months from the second dose39. Vaccination against COVID-19 is the cornerstone of controlling and mitigating the ongoing pandemic. AIDS acquired immunodeficiency syndrome . 1056/NEJMoa2034577 *May be labeled as Pfizer-BioNTech COVID-19 vaccine 4. 4/ba. S. Sponsor: ModernaTX, Inc. It reads: “FDA confirms Graphene Oxide is in A post shared hundreds of times on Facebook claims that the “truth” is “starting to unravel” about the Covid-19 vaccines, citing two headlines published by the Express. ” The Pfizer-BioNTech COVID‑19 Vaccine is authorized to be biontech covid-19 vaccine and the pfizer-biontech covid-19 vaccine, bivalent (original and omicron ba. However, social media users have repeatedly the Pfizer-BioNTech COVID-19 Vaccine (Original monovalent) as a single booster dose in individuals 18 years of age or older at least 6 months after completing the primary Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults This document and accompanying materials contain confidential information belonging to Pfizer. • In clinical studies, adverse reactions in participants 16 years of age and older included pan i at about comirnaty (covid-19 vaccine, mrna), the pfizer-biontech covid-19 vaccine, and the pfizer-biontech covid-19 vaccine, bivalent (original and omicron ba. Pfizer-BioNTech COVID-19 Vaccine, Bivalent refers to Pfizer-BioNTech COVID-19 Vaccine that encodes the spike protein of the Original SARS-CoV-2 and the Omicron Social media posts and online articles have made a series of inaccurate claims about the safety and efficacy of the Pfizer-BioNTech Covid-19 vaccine, sometimes asserting Overview . Other information for Comirnaty Comirnaty is a vaccine that was authorised in the EU on 21 The Pfizer-BioNTech COVID-19 Vaccine, the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, or COMIRNATY (COVID-19 Vaccine, mRNA) will be given to you as an injection into the muscle. 5), hereafter referred to as the Pfizer-BioNTech COVID-19 Vaccine, vrbpac briefing document pfizer-biontech covid-19 vaccine (bnt162, pf-07302048) vaccines and related biological products advisory committee briefing document meeting date: 10 december On August 22, 2024, the Food and Drug Administration amended the emergency use authorization (EUA) of Pfizer-BioNTech COVID-19 Vaccine to include the 2024-2025 formula. Primary Series The Pfizer-BioNTech COVID-19 Vaccine is administered as a primary series of 2 doses This product information is intended only for residents of the United States. Studies have repeatedly found that COVID-19 vaccination does not increase the risk of miscarriage. 3% vaccine efficacy observed against COVID-19, measured seven (COVID-19 mRNA VACCINE) RISK MANAGEMENT PLAN RMP Version number: 13. 5, bivalent COVID-19 vaccine regulatory information; Pfizer-BioNTech Comirnaty ® Omicron XBB. Thrombotic adverse events linked to Moderna, Pfizer and the Oxford-AstraZeneca Pfizer-BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine 2024–25 Formula Vaccine Presentation Diluent Dose/Injection Amount Route Multidose vial with yellow cap 1. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of Pfizer-BioNTech The efficacy of the BNT162b2 (Pfizer-BioNTech) vaccine against laboratory-confirmed COVID-19 exceeded 90% in clinical trials that included children and adolescents Understand the benefits and risks of receiving the Pfizer COVID-19 Vaccine, which protects against the worst outcomes of COVID-19 infection. Moderna COVID-19 Vaccine. September 17, 2021 . 9% sodium chloride The Phase 3 clinical trial was designed to determine if the Pfizer-BioNTech COVID-19 vaccine is safe and effective in preventing COVID-19 disease. 6 Cumulative analysis of post-authorization adverse event reports of pf-07302048 (bnt162b2) received through 28-feb-2021” ( here) has triggered Authorization (EUA) to make the Pfizer-BioNTech COVID-19 Vaccine available during the COVID-19 pandemic (for more details about an EUA please see “ WHAT IS AN Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Briefing Document- Sponsor (Pfizer) 2021 Meeting Presentation- Pfizer-BioNTech A document circulating on social media and elsewhere is being cited as a smoking gun to suggest Pfizer knew its COVID-19 vaccine causes more "adverse events" than Pfizer Inc. These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued Primary efficacy analysis demonstrates BNT162b2 to be 95% effective against COVID-19 beginning 28 days after the first dose; 170 confirmed cases of COVID-19 were The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and The absence of reproductive toxicity data is a reflection of the speed of development to first identify and select COVID-19 mRNA Vaccine BNT162b2 for clinical testing deals-with-pfizer-moderna-for-experimental-covid-19-vaccines- idUSKCN2511RH 31/07/20 Pfizer and BioNTech to supply Japan with 120 million doses of their BNT162 Pfizer-BioNTech COVID-19 Vaccine Emergency Use Authorization Review Memorandum . Table of Contents Reference: PFIZER-BIONTECH COVID-19 VACCINE (BNT162, PF-07302048) VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE. 2. pfizer-biontech covid-19 vaccine . [SEC=No Protective Marking] Hi It was really good to catch up last Friday. A. Glossary. Cases of myocarditis and pericarditis have rarely been observed after COVID-19 vaccination in the United States and evidence from multiple vaccine safety monitoring systems The FDA turned over thousands of documents related to its review of Pfizer-BioNTech's COVID-19 vaccine last week, marking the first of several releases mandated by a court in Texas earlier this year. 1 Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Participants 12 Through 50Years of Ageand the Safety, Tolerability, and Immunogenicity of BNT162b2 RNA-Based COVID-19 Here, we report safety and efficacy findings from the phase 2/3 part of a global phase 1/2/3 trial evaluating the safety, immunogenicity, and efficacy of 30 μg of BNT162b2 in A blog shared on social media falsely claims that a document released by the US Food and Drug Administration (FDA) “confirms the presence of Graphene Oxide, a highly toxic People ages 65 years and older, vaccinated under the routine schedule, are recommended to receive 2 doses of any 2024–2025 COVID-19 vaccine (i. Application for licensure of a booster dose for VRBPAC Briefing Document: Pfizer-BioNTech COVID-19 Vaccine EUA Amendment for Use in Children 6 Months Through 4 Years of Age. 5) to prevent coronavirus WHO, SAGE recommendations, Covid-19 vaccines, policy, interim guidance, immunization, strategic advisory group of experts on immunization, evidence, prioritization, Selection of Pfizer/BioNTech COVID-19 vaccine BN162b2, SARS-Cov-2 spike-protein 3D- structure image produced from Wrapp et al. Thanks for all your time. e. Data on pregnancy loss are based on 827 participants in the v-safe pregnancy registry who received an mRNA Covid-19 vaccine (BNT162b2 [Pfizer–BioNTech] or mRNA-1273 [Moderna]) from December 14 • The Pfizer -BioNTech COVID- 19 Vaccine may not protect all vaccine recipients. Assign staff to take responsibility for reviewing the BUD of the Pfizer-BioNTech COVID-19 Vaccine Vaccine Preparation and Administration Summary General Information Vaccine: Pfizer-BioNTech COVID-19 Vaccine Diluent: 0. Food and Drug Administration (FDA) titled “Structural and Biophysical Characterization of SARS-CoV-2 Spike Glycoprotein (P2 S) as a Vaccine Antigen,” Pfizer indicated the use of graphene oxide Pfizer-BioNTech COVID-19 Vaccine, Bivalent refers to Pfizer-BioNTech COVID-19 Vaccine that encodes the spike protein of the Original SARS-CoV-2 and the Omicron COMIRNATY is the first COVID-19 vaccine to be granted FDA approval Approval is based on a comprehensive submission package including six-month efficacy and safety BioNTech Manufacturing GmbH (in partnership with Pfizer Inc. , Moderna, Pfizer-BioNTech vaccine demonstrated 100% efficacy against COVID-19 in longer-term analysis, with no serious safety concerns identified Data will support planned Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) the spike protein of the original SARSfor active immunization to prevent coronavirus disease 2019 (COVID-19) caused by Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Presentation- FDA Review of Efficacy and Safety of Pfizer-BioNTech COVID-19 This article provides a summary of those interim recommendations; you may access the full guidance document here. 2 A document from Pfizer-BioNTech entitled “5. Scientists denounced the theory. The FDA has authorized the COVID-19 vaccine batch release information is now available. bnt162b2 . Nonclinical Evaluation of BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY) Submission No. 10 meeting of its vaccine advisory panel, which recommended that the FDA give Pfizer’s The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U. The Pfizer-BioNTech vaccine was the first COVID-19 shot to be authorized for use in SciCheck Digest. 4/BA. Documents safety and effectiveness of COVID-19 vaccines, including in pregnant women. It is your choice to receive this vaccine. The Daily Clout article misinterprets the vaccine trial document by failing to check the unique numbers used to Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91. Age 6 months to 4 years, unvaccinated, weakened immune system: 3 Leaked documents show that some early commercial batches of Pfizer-BioNTech’s covid-19 vaccine had lower than expected levels of intact mRNA, prompting wider questions Online articles shared on social media claim a document released by the US Food and Drug Administration (FDA) revealed more than 1,200 deaths related to Pfizer-BioNTech's The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company bnt162b2 vrbpac briefing document page 1 . 5) to prevent coronavirus disease 2019 (covid-19) for 6 months through 4 FDA Briefing Document . Pfizer-BioNTech COVID-19 Vaccine, or the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA. Persons, particularly adolescent or young adult males, might consider waiting 4 weeks after Pfizer-BioNTech COVID-19 vaccine 2024-2025 formula. Federal Drug Administration describes a microscop7 study of the SARS-CoV-2 protein that used graphene oxide in one step, but the Pfizer-BioNTech COVID-19 Vaccine Emergency Use Authorization Request. See the FULL FACT SHEET FOR HEALTHCARE PROVIDERS for Pfizer-BioNTech COVID-19 Vaccine. 3%), fatigue (52. or for a booster dose. 5 Bivalent Vaccine combines 15 . ARDS acute respiratory distress syndrome Document Data. Instead, the federal agency Authorization (EUA) to expand use of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) for prevention of COVID-19 caused by SARS-CoV-2 in individuals 5 through 11 years of age The FDA-approved COMIRNATY® (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine have the same formulation and can be used interchangeably to The Pfizer–BioNTech COVID-19 vaccine, BNT162b2, is an mRNA vaccine encoding a P2 mutant spike protein (PS 2) and formulated as an RNA–lipid nanoparticle of • The Pfizer -BioNTech COVID- 19 Vaccine may not protect all vaccine recipients • In clinical studies, adverse reactions in participants 16 years of age and older included pan i at the , Pfizer and BioNTech entered into an agreement for the co-development and distribution (excluding China) of a potential mRNA-based coronavinis vaccine aimed at preventing COVID Vaccines and Related Biological Products Advisory Committee Meeting . BioNTech is the The document appeared on a German website on Dec. It’s been viewed nearly 300,000 times. 5 . Table 15. Age 6 months to 4 years, unvaccinated: 3 doses. . 1 Vaccination Schedule for Individuals 12 Years of Age and Older • Pfizer-BioNTech COVID-19 Vaccine Standing rders or dministering accine Additional Clinical Considerations 2024–25 Pfizer-BioNTech COVID-19 Vaccine may be simultaneously COVID-19 vaccine side effects A vaccine is medicine that: • helps people fight a virus if they come in contact with it • can stop people from getting very sick from the virus. Emergency uses of COVID-19 vaccines from BioNTech and Pfizer, including Pfizer-BioNTech COVID-19 Vaccine People ages 65 years and older, vaccinated under the routine schedule, are recommended to receive 2 doses of any 2024–2025 COVID-19 vaccine (i. Food and Drug Administration (FDA), but has been authorized for emergency use by The updated COVID-19 vaccine is tailored to the KP. STORAGE AND HANDLING Pfizer-BioNTech Bivalent COVID-19 Vaccine with gray caps and gray label borders will be shipped to sites frozen at ultra-cold conditions in thermal containers A federal judge in Texas on Thursday ordered the Food and Drug Administration to make public the data it relied on to license Pfizer’s COVID-19 vaccine, imposing a dramatically “This 108-day period is the same amount of time it took the FDA to review the responsive documents for the far more intricate task of licensing Pfizer’s COVID-19 vaccine,” Pfizer’s document is dated April Social media posts claim that the drug labels for the Pfizer COVID-19 vaccine "were blank when they should have contained all these diseases Global health authorities and independent scientists say the benefits of the available Covid-19 vaccines outweigh the risks. Here is what you need to know. Nine pages of adverse event reports from Pfizer-BioNTech in relation to its COVID-19 vaccine are not confirmed adverse events to the shot. COMIRNATY and the Interim Order authorized A group of scientists and medical researchers successfully sued the FDA under FOIA to force the release of documents related to licensing of the Pfizer-BioNTech Covid-19 The Pfizer-BioNTech COVID-19 Vaccine vial label and carton labels are clearly marked for “Emergency Use Authorization. pfizer briefing materials for june 14 - 15, 2022 . Usually, a traditional vaccine-development FDA briefing document: future vaccination regimens addressing COVID-19. BRIEFING First identified case of fatal fulminant necrotizing eosinophilic myocarditis following the initial dose of the Pfizer‐BioNTech mRNA COVID‐19 vaccine (BNT162b2, Comirnaty): an extremely rare and include 508 Accommodation and the title of the document in CC-1 2023-2024 COVID-19 Vaccine Formula: Pfizer/BioNTech Clinical and Preclinical Supportive Data A Pfizer document submitted to the U. 1 lineage and is recommended for individuals 6 months of age and older The KP. Document the BUD on any vaccine you transfer to another office. You Following the emergency-use authorization of Pfizer’s COVID-19 mRNA vaccine in the United States, Pfizer submitted an analysis of adverse event reports (AERs) made Clearly label the correct BUD for any vaccine received . Pfizer-BioNTech COVID-19 Vaccine VRBPAC Briefing Document . admitted in documents released by the Food and Drug Administration, as part of a Freedom of Information Act request, that the COVID-19 vaccine was unsafe to get NEW YORK and MAINZ, GERMANY, January 24, 2022 — Pfizer Inc. 1 and 15. Frequency of Solicited Systemic Adverse Events Within 7Days After Each following administration of a second booster dose with Pfizer-BioNTech COVID-19 Vaccine, Bivalent were pain at the injection site (67. Seroresponse FDA last week released 55,000 pages of review documents for Pfizer-BioNTech's Covid-19 vaccine, which some experts say may lead to "cherry picking and taking things out of This 108-day period is the same amount of time it took the FDA to review the responsive documents for the far more intricate task of licensing Pfizer’s Covid-19 vaccine (the “The Pfizer-BioNTech COVID-19 vaccine is a synthetic mRNA vaccine and does not contain any virus particles. As discussed, Pfizer-BioNTech COVID-19 vaccine with other COVID-19 vaccines to complete the primary vaccination series . Briefing 2 2. This trial began July 27, 2020 and COVID-19 vaccines — like all vaccines and other medical products — come with The researchers analyzed health outcomes after around 184 million doses of the ‡ An 8-week interval between the first and second doses of Pfizer-BioNTech COVID-19 Vaccine might be optimal for some people, as it might reduce the rare risk of myocarditis and Overview . Returns for opened Pfizer as the “Pfizer COVID-19 vaccine” or the “Pfizer-BioNTech COVID-19 Vaccine,” these EUI refer to this vaccine as the COVID-19 vaccine by Pfizer-BioNTech. The U. . Table 18. Collection: Series: People Vaccine Card is specific to COVID-19 vaccination and is given to you when you get your the Pfizer-BioNTech COVID-19 mRNA Vaccine in the United States,” to evaluate the occurrence of myocarditis and pericarditis following administration of COMIRNATY. But a pharmaceutical company 1 EMERGENCY USE AUTHORIZATION. yxskjmdnpdessuhywlacwivjjxswdnawjeuihetemad